Emd Serono Drug Patent Portfolio

Emd Serono owns 9 orange book drugs protected by 13 US patents with Luveris having the least patent protection, holding only 1 patent. And Egrifta with maximum patent protection, holding 6 patents. Given below is the list of Emd Serono's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7741268 Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant 02 Apr, 2024 Expired
US7316997 GH secretagogues and uses thereof 14 Aug, 2023 Expired
US8314066 GH secretagogues and uses thereof 14 Aug, 2023 Expired
US8435945 GH secretagogues and uses thereof 14 Aug, 2023 Expired
US6706681 HCG liquid formulations 16 Mar, 2021 Expired
US7144577 Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy 14 Jul, 2020 Expired
US7563763 FSH and FSH variant formulations, products and methods 23 Aug, 2019 Expired
US7446090 FSH formulation 23 Aug, 2019 Expired
US5898030 hGH containing pharmaceutical compositions 27 Apr, 2016 Expired
US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same 16 Jun, 2015 Expired
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015 Expired
US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency 26 May, 2015 Expired
US6020311 GRF analogs with increased biological potency 26 May, 2015 Expired


Given below is the list of recent legal activities going on the following drug patents of Emd Serono.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 08 Jul, 2024 US8314066
Payment of Maintenance Fee, 12th Year, Large Entity 08 Dec, 2021 US7741268
Expire Patent 23 Aug, 2021 US7563763
Maintenance Fee Reminder Mailed 08 Mar, 2021 US7563763
Expire Patent 07 Dec, 2020 US7446090
Payment of Maintenance Fee, 8th Year, Large Entity 21 Oct, 2020 US8435945
Maintenance Fee Reminder Mailed 22 Jun, 2020 US7446090
Payment of Maintenance Fee, 8th Year, Large Entity 18 May, 2020 US8314066
Payment of Maintenance Fee, 12th Year, Large Entity 24 Jun, 2019 US7316997
Payment of Maintenance Fee, 12th Year, Large Entity 24 May, 2018 US7144577
Payment of Maintenance Fee, 8th Year, Large Entity 07 Dec, 2017 US7741268
Sequence Moved to Public Database 09 May, 2013 US8435945
Patent Issue Date Used in PTA Calculation 07 May, 2013 US8435945
Recordation of Patent Grant Mailed 07 May, 2013 US8435945
Email Notification 18 Apr, 2013 US8435945


Emd Serono's Drug Patent Litigations

Emd Serono's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jul 06, 2000, against patent number US6706681. The petitioner , challenged the validity of this patent, with SAMARITANI et al as the respondent. Click below to track the latest information on how companies are challenging Emd Serono's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US6706681 July, 2000 Decision
(23 Jan, 2002)
SAMARITANI et al


Emd Serono's Family Patents


Family Patents



Emd Serono Drug List

Given below is the complete list of Emd Serono's drugs and the patents protecting them.


1. Egrifta

Egrifta is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7316997 GH secretagogues and uses thereof 14 Aug, 2023
(1 year, 3 months ago)
Expired
US8314066 GH secretagogues and uses thereof 14 Aug, 2023
(1 year, 3 months ago)
Expired
US8435945 GH secretagogues and uses thereof 14 Aug, 2023
(1 year, 3 months ago)
Expired
US7144577 Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy 14 Jul, 2020
(4 years ago)
Expired
US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency 26 May, 2015
(9 years ago)
Expired
US6020311 GRF analogs with increased biological potency 26 May, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Egrifta's drug page


2. Gonal-f

Gonal-f is protected by 3 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7563763 FSH and FSH variant formulations, products and methods 23 Aug, 2019
(5 years ago)
Expired
US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same 16 Jun, 2015
(9 years ago)
Expired
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f's drug page


3. Gonal-f Rff

Gonal-f Rff is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same 16 Jun, 2015
(9 years ago)
Expired
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f Rff's drug page


4. Gonal-f Rff Pen

Gonal-f Rff Pen is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7741268 Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant 02 Apr, 2024
(8 months ago)
Expired
US7446090 FSH formulation 23 Aug, 2019
(5 years ago)
Expired
US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same 16 Jun, 2015
(9 years ago)
Expired
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gonal-f Rff Pen's drug page


5. Luveris

Luveris is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Luveris's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Ovidrel

Ovidrel is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6706681 HCG liquid formulations 16 Mar, 2021
(3 years ago)
Expired
US5767251 Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof 16 Jun, 2015
(9 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ovidrel's drug page


7. Saizen

Saizen is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5898030 hGH containing pharmaceutical compositions 27 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Saizen's drug page


8. Serostim

Serostim is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5898030 hGH containing pharmaceutical compositions 27 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Serostim's drug page


9. Zorbtive

Zorbtive is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5898030 hGH containing pharmaceutical compositions 27 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zorbtive's drug page


Emd Serono News

FDA broadens labeling for Novartis and Roche's popular drug, transforms EMD Serono's treatment for non-small cell lung cancer ...

16 Feb, 2024

See More